Paul Dalessio

Paul Dalessio specializes in digital and social strategy for pharmaceutical and life sciences companies, delivering disease state awareness, branded product information, and targeted data announcements. He develops compliant digital programs that educate HCPs, patients, and caregivers, while amplifying key narratives across platforms like Meta, LinkedIn, and YouTube. A member of FleishmanHillard’s social healthcare strategy group, Paul integrates social media into corporate operations, driving market influence through unbranded and branded campaigns. Since joining in 2004, he has led transformative communications for brands such as AstraZeneca, Novo Nordisk, and Johnson & Johnson, advancing healthcare engagement through innovative, targeted digital strategies.